Cortical Thickness and Anxiety Symptoms Among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging

J Neuropsychiatry Clin Neurosci. 2017 Winter;29(1):60-66. doi: 10.1176/appi.neuropsych.15100378. Epub 2016 Aug 31.

Abstract

The authors conducted a cross-sectional study to investigate the association between anxiety symptoms and cortical thickness, as well as amygdalar volume. A total of 1,505 cognitively normal participants, aged ≥70 years, were recruited from the Mayo Clinic Study of Aging in Olmsted County, Minnesota, on whom Beck Anxiety Inventory and 3T brain MRI data were available. Even though the effect sizes were small in this community-dwelling group of participants, anxiety symptoms were associated with reduced global cortical thickness and reduced thickness within the frontal and temporal cortex. However, after additionally adjusting for comorbid depressive symptoms, only the association between anxiety symptoms and reduced insular thickness remained significant.

Keywords: Biological Markers; Neuropsychology.

MeSH terms

  • Aged
  • Aging / pathology*
  • Aging / psychology*
  • Anxiety / diagnostic imaging*
  • Anxiety / epidemiology
  • Apolipoprotein E4 / genetics
  • Cerebral Cortex / diagnostic imaging*
  • Comorbidity
  • Cross-Sectional Studies
  • Depression / diagnostic imaging
  • Depression / epidemiology
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Minnesota / epidemiology
  • Organ Size
  • Psychiatric Status Rating Scales

Substances

  • Apolipoprotein E4